BridgeMD
New treatment option for Sedentary Behavior
Official title A Intervention for Reducing Sedentary Behaviour Among Prostate Cancer Survivors
ClinicalTrials.gov ID: NCT05214937
What this study is testing
- What it's testing
- This randomized controlled trial (RCT) will aim to examine the effect of a 12-week behavioural intervention on changing the sedentary behaviours (SB) of prostate cancer survivors (PCS) compared to a control group (FitBit-only group). PCS in the intervention group will receive a FitBit and 6 behavioural support sessions with a movement specialist guided by behavioural theory (i.e., the Multi-Process Action Control [M-PAC]).
- Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 and older, men only
You may be able to join if
- \>= 18 years of age
- Diagnosed with localized or asymptomatic metastatic primary prostate cancer
- Not currently undergoing radiation or chemotherapy
- Proficient in English
- Not physically active (self report \<150 minutes of moderate-to-vigorous physical activity per week)
You likely can't join if
- Not planning to live in Canada for the next 12 months
- A medical condition that prohibits walking (e.g., severe knee or hip arthritis)
- Presence of other primary or recurrent invasive cancer (i.e., other than non-melanoma skin cancer)
- Have had a prior fall within the last 12-months
- Use a gait aid device
See the full eligibility criteria
- \>= 18 years of age
- Diagnosed with localized or asymptomatic metastatic primary prostate cancer
- Not currently undergoing radiation or chemotherapy
- Proficient in English
- Not physically active (self report \<150 minutes of moderate-to-vigorous physical activity per week)
- Self-report \>8 hours of daily sedentary behaviour
- In the contemplation or preparation stage for motivational readiness to change as determined by the Stages of Change Questionnaire
- Access to a smartphone, tablet, or computer
- No cardiac contraindications (e.g., unstable angina, arrhythmia, heart failure, aortic stenosis)
- Medical clearance from a primary health care provider (if necessary)
- Currently residing in Canada
- Not planning to live in Canada for the next 12 months
- A medical condition that prohibits walking (e.g., severe knee or hip arthritis)
- Presence of other primary or recurrent invasive cancer (i.e., other than non-melanoma skin cancer)
- Have had a prior fall within the last 12-months
- Use a gait aid device
The study team makes the final eligibility decision.
Where it's taking place
- Toronto, Ontario, Canada
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling male, 18 years and older. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Toronto, Ontario, Canada. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.